Experimental Alzheimer's Drug Shows Promise in Delaying Symptoms

Scientists report that long-term use of gantenerumab might prevent cognitive decline in people with genetic predisposition to early-onset Alzheimer's.

https://cdn.decrypt.co/wp-content/uploads/2025/03/brain-pills-gID_7.png" class="embedded-image" loading="lazy">@png

https://decrypt.co/311099/experimental-alzheimers-drug-shows-promise